Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01374048
Other study ID # 97-88
Secondary ID
Status Completed
Phase N/A
First received June 13, 2011
Last updated June 13, 2011

Study information

Verified date June 2011
Source Umeå University
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review Board
Study type Observational

Clinical Trial Summary

Patients are subjected to simultaneous intracranial and lumbar puncture pressure measurements. This study focus on intracranial pulse amplitude. Hypothesis: Intracranial pressure amplitude is reflected by lumbar puncture pressure amplitude.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 55 Years to 78 Years
Eligibility Inclusion Criteria:

- Clinical diagnosis of Idiopathic Normal Pressure Hydrocephalus

Exclusion Criteria:

- Known cause of hydrocephalus

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Umeå University
See also
  Status Clinical Trial Phase
Completed NCT00221091 - Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus Phase 2
Completed NCT01570257 - A Trial of High and Low Pressure Level Settings on a Programmable Ventriculoperitoneal Shunt Valve for Idiopathic Normal Pressure Hydrocephalus N/A
Recruiting NCT04998175 - Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH) N/A
Recruiting NCT06428734 - Clinical Outcome in Patients With INPH
Completed NCT01319136 - Improved Analysis Methods for Infusion Tests N/A
Active, not recruiting NCT04795089 - Gait Pattern and Experienced Global Change After Shunt Surgery in Idiopathic Normal Pressure Hydrocephalus
Active, not recruiting NCT02495610 - Novel Parameters for the Prediction of Ventriculoperitoneal Shunting Efficacy in Patients With iNPH N/A